The benefits of ADCs include: - Targeted Delivery: The monoclonal antibody ensures that the cytotoxic drug is delivered specifically to cancer cells, sparing healthy tissues. - Reduced Side Effects: By minimizing exposure to non-cancerous cells, ADCs reduce the adverse side effects commonly associated with chemotherapy. - Increased Efficacy: ADCs can deliver highly potent cytotoxic drugs directly to cancer cells, potentially overcoming resistance to traditional therapies.
